CSIMarket
 


Surmodics Inc  (SRDX)
Other Ticker:  
 
 

SRDX's Net Cash Flow Growth by Quarter and Year

Surmodics Inc's Net Cash Flow results by quarter and year




SRDX Net Cash Flow (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter September 22.24 -4.64 14.02 21.18
III Quarter June -7.25 -1.94 12.41 -15.15
II Quarter March 7.43 -4.50 4.97 0.00
I Quarter December -1.08 -31.02 -5.60 0.00
FY   21.34 -42.10 25.80 6.03



SRDX Net Cash Flow fourth quarter 2023 Y/Y Growth Comment
Surmodics Inc in the fourth quarter 2023 achieved Net Cash Flow of $ 22.24 millions compare to net cash outflow recorded in same quarter a year ago.

According to the results reported in the fourth quarter 2023, Surmodics Inc achieved the best Net Cash Flow growth in Medical Equipment & Supplies industry. While Surmodics Inc' s Net Cash Flow no change of % ranks overall at the positon no. in the fourth quarter 2023.




SRDX Net Cash Flow ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter September - - -33.81 % -
III Quarter June - - - -
II Quarter March - - - -
I Quarter December - - - -
FY   - - 327.86 % -

Financial Statements
Surmodics Inc's fourth quarter 2023 Net Cash Flow $ 22.24 millions SRDX's Income Statement
Surmodics Inc's fourth quarter 2022 Net Cash Flow $ -4.64 millions Quarterly SRDX's Income Statement
New: More SRDX's historic Net Cash Flow Growth >>


SRDX Net Cash Flow (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter September - - 12.97 % -
III Quarter June - - 149.7 % -
II Quarter March - - - -
I Quarter December - - - -
FY (Year on Year)   - - 327.86 % -




Net Cash Flow fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Cash Flow fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Cash Flow by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Surmodics Inc's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


SRDX's IV. Quarter Q/Q Net Cash Flow Comment
This reversal of fortune IV. Quarter 2023where Surmodics Inc delivered Net Cash Flow of $ 22.24 millions could is starting point of better performance.Surmodics Inc announced in the IV. Quarter 2023 Net Cash Flow of $ 22.24 millions compare to net cash outflow recorded in previos quarter.

Within Medical Equipment & Supplies industry Surmodics Inc achieved highest sequential Net Cash Flow growth. While Surmodics Inc's Net Cash Flow growth quarter on quarter, overall rank is .


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


SRDX's IV. Quarter Q/Q Net Cash Flow Comment
This turnaround IV. Quarter 2023where Surmodics Inc posted Net Cash Flow of $ 22.24 millions may be considered as a starting point of improved performance.Surmodics Inc announced in the IV. Quarter 2023 Net Cash Flow of $ 22.24 millions compare to net cash outflow recorded in previos quarter.

Within Medical Equipment & Supplies industry Surmodics Inc achieved highest sequential Net Cash Flow growth. While Surmodics Inc's Net Cash Flow growth quarter on quarter, overall rank is .


Surmodics Inc's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
Cumulative Net Cash Flow 12 Months Ending $ 21.35 $ -5.53 $ -0.22 $ -12.16 $ -42.10
Y / Y Net Cash Flow Growth (TTM) - - - - -
Year on Year Net Cash Flow Growth Overall Ranking # # # # #
Seqeuential Net Cash Flow Change (TTM) - - - - -
Seq. Net Cash Flow Growth (TTM) Overall Ranking # # # # #




Cumulative Net Cash Flow growth Comment
In the Sep 30 2023 period, Surmodics Inc had cumulative twelve months Net Cash Flow of $ 21 millions compare to net cash outflow of $ -42 millions a year ago.

Surmodics Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Cash Flow growth Comment
In the Sep 30 2023 period, Surmodics Inc had cumulative twelve months Net Cash Flow of $ 21 millions compare to net cash outflow of $ -42 millions a year ago.

Surmodics Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Cash Flow Growth
Medical Equipment & Supplies Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
SRDX's Net Cash Flow Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for SRDX's Competitors
Net Cash Flow Growth for Surmodics Inc's Suppliers
Net Cash Flow Growth for SRDX's Customers

You may also want to know
SRDX's Annual Growth Rates SRDX's Profitability Ratios SRDX's Asset Turnover Ratio SRDX's Dividend Growth
SRDX's Roe SRDX's Valuation Ratios SRDX's Financial Strength Ratios SRDX's Dividend Payout Ratio
SRDX's Roa SRDX's Inventory Turnover Ratio SRDX's Growth Rates SRDX's Dividend Comparisons



Companies with similar Net Cash Flow no change for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Sep 30 2023
Nascent Biotech Inc-4.04%$ -4.038 millions
Halozyme Therapeutics Inc -5.63%$ -5.629 millions
Vystar Corporation-6.05%$ -6.052 millions
Ideaya Biosciences Inc -7.27%$ -7.268 millions
Phibro Animal Health Corporation-7.87%$ -7.874 millions
Luna Innovations Inc-9.06%$ -9.058 millions
Puma Biotechnology Inc -13.53%$ -13.534 millions
Fulgent Genetics Inc -14.21%$ -14.211 millions
Prestige Consumer Healthcare Inc -16.52%$ -16.522 millions
Omniab Inc -20.57%$ -20.566 millions
Gossamer Bio Inc -22.91%$ -22.914 millions
Alnylam Pharmaceuticals Inc -24.60%$ -24.599 millions
Emmaus Life Sciences Inc -26.90%$ -26.904 millions
Kala Bio inc -27.38%$ -27.384 millions
Protara Therapeutics Inc -29.54%$ -29.540 millions
Msa Safety Incorporated-31.72%$ -31.716 millions
Avalo Therapeutics Inc -32.14%$ -32.143 millions
Biovie Inc -32.27%$ -32.265 millions
Veracyte inc -32.97%$ -32.966 millions
Coherus Biosciences inc -35.07%$ -35.068 millions
Biomarin Pharmaceutical Inc-35.76%$ -35.762 millions
International Stem Cell Corporation-40.00%$ -40.000 millions
Arvinas Inc -42.82%$ -42.822 millions
89bio Inc -44.85%$ -44.846 millions
Assertio Holdings inc -46.56%$ -46.561 millions
Infusystem Holdings Inc-48.08%$ -48.077 millions
Eqrx Inc -48.96%$ -48.965 millions
Privia Health Group Inc -49.62%$ -49.617 millions
Nektar Therapeutics-49.69%$ -49.693 millions
Avinger Inc -53.79%$ -53.788 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com